US-based University Hospitals Case Medical Centre (UH Case Medical Centre) has deployed a new non-invasive imaging technology, computed fractional flow reserve (FFRCT) specifically developed for coronary artery disease.
Located in Cleveland, Ohio, the hospital is offering a non-invasive test, which will provide insight on both the extent of the blockage, as well as whether it is impacting blood flow to the heart.
Go deeper with GlobalData
Developed by HeartFlow, the FFRCT technology combines non-invasive 3D imaging with computational fluid dynamics technology to produce detailed models of a patient’s cardiovascular anatomy.
HeartFlow chairman John Stevens said: "Research on this technology began more than 20 years ago and we have continued to refine it over time to ensure we were able to provide precision, safety and efficiency.
"It is incredibly gratifying to finally give clinicians in the United States the chance to use our technology to help treat their patients."
To provide mathematically FFRCT values from images derived using non-invasive computed tomography (CT) angiography, the technology performs millions of complex equations simulating blood flow in the coronary arteries.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAccording to the hospital, FFRCT values show pressure differences around a lesion to determine whether it is likely to reduce blood flow to the heart. It allows physicians to implement the right course of action for each patient.
University Hospitals operates 15 hospitals, 28 outpatient health centres and primary care physician offices in 15 counties of the US.
